Despite New DOAC Use, Anticoagulation Clinics Serve Purpose

U-M cardiologists say anticoagulation clinics still hold a vital role in patient care, even as new drugs claim to reduce the need.

4:12 PM

Author | Shantell M. Kirkendoll

Visits to anticoagulation clinics may no longer be part of the routine for patients taking blood thinners for atrial fibrillation or venous thromboembolism.

That doesn't mean, however, the facilities don't serve a purpose.

The clinics serve warfarin-treated patients to help monitor and manage the medication. But since 2009, use of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) has grown as an alternative to warfarin. Much of the marketing around DOACs — the TV ads are hard to miss — emphasize they don't necessarily require frequent clinic visits for monitoring.

"Many wondered if these new drugs would run anticoagulation clinics out of business," says Geoffrey Barnes, M.D., M.Sc., cardiologist and vascular medicine specialist at the University of Michigan Frankel Cardiovascular Center. "But the clinics can have a role no matter what anticoagulant patients are on."

In the American Heart Association's journal Circulation: Cardiovascular Quality and Outcomes, Barnes and colleagues expand the role of traditional anticoagulation clinics and reimagine them as cost-saving medication safety hubs.

He describes three ways the nation's 3,000 clinics can continue serving patients and doctors:

  • Clearing through clutter. Specialty pharmacists and nurses can help select the most appropriate drug and dose from a growing list of anticoagulants, including warfarin, and review with patients how much blood clot prevention will cost. There are fewer diet-drug and drug-drug interactions with DOACs, but there are still some medicines to avoid. "Clinic providers can spend more time with patients than most primary care or specialty physicians," Barnes says. Any prescribing physician will know to check renal function upfront, but long-term monitoring is often overlooked. Clinic providers can establish a regular renal function monitoring plan, and adjust dosage to prevent life-threatening bleeding if renal function declines.

  • Encouraging long-term adherence. This is especially important for DOAC-treated patients, for whom skipping one or two doses may leave them unprotected from a deadly stroke or pulmonary embolism. A recent Veterans Affairs study demonstrated that long-term monitoring of dabigatran treatment by an anticoagulation clinic with support from pharmacists was associated with the highest likelihood for medication adherence. Clinic visits were scheduled at least every three months in major trials comparing warfarin with DOACs. Clinic check-ins have been recommended every three to six months by the European Heart Rhythm Association.

  • Acting as the "go-to team" for periprocedural management. Patients on blood thinners may need to interrupt their anticoagulation therapy when undergoing a teeth cleaning, heart catheterization, colonoscopy or joint replacement. The time needed to stop an anticoagulant before or after a procedure varies greatly depending on medication, a patient's renal function and the bleeding risk of the procedure. "I've seen patients try to coordinate opinions from multiple providers, potentially from different health systems, and it's a struggle," Barnes says. An anticoagulation clinic can help with answers and coordination.

Clinics as safety centers

Beyond the care of patients taking anticoagulants, the existing anticoagulation clinic infrastructure could be leveraged to serve as medication safety clinics for patients taking other potentially dangerous cardiovascular medicines, the authors say.

Patients taking mineralocorticoid receptor antagonist for hypertension or heart failure could be monitored for potassium and renal function. Recent studies have shown that only half of patients taking amiodarone receive the recommended liver and thyroid screening. Both groups of patients could be followed at a medication safety clinic.

Despite the examples and opportunities, the authors believe the greatest barrier to reimagining the anticoagulation clinic is cost. As use of DOACs increases, it might be tempting to discourage use of anticoagulation clinics and avoid paying for these services.

"But we have to remember why the clinics were created in the first place: to reduce bleeding risk and avoid stroke and pulmonary embolism," Barnes says. "When we reduce these complications we've improved health care's bottom line."


More Articles About: Industry DX Preventive Cardiology Cardiovascular: Preventive Cardiology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories doctor swabs man's mouth with mask and eye glass gear on
Health Lab
DNA testing at the doctor’s office
A human genetics experts discusses how these DNA tests might be useful in practice and what cautions remain.
Health Lab
Why Does Cardiac Arrest, a Leading Killer, Receive Only 0.2 Percent of NIH Funding?
A new study examining allocations of NIH research dollars finds lagging support for cardiac arrest, which kills hundreds of thousands of Americans each year.
Person's hand holding an aspirin tablet with a glass of water nearby
Health Lab
An aspirin a day? Some older adults who take it may be following outdated advice
Many people aged 50 to 80 who said they take aspirin multiple times a week may not need to do so and could be causing health risks, according to National Poll on Healthy Aging.
Adult performs CPR on a young athlete, illustration with red and blue figures
Health Lab
Sudden cardiac arrest in young athletes: 5 things parents should know
Sudden cardiac arrest in young athletes: 5 things parents should know
Graphic showing pills, a heart and brain with data on aspirin use
Health Lab
Aspirin can prevent a second heart attack or stroke, but many don’t use it
Washington University School of Medicine and Michigan Medicine researchers found that fewer than half of people who have experienced a heart attack or stroke use aspirin to prevent a second one.
Illustration of a magenta heart with white plaque on a golden background.
Health Lab
What is heart disease?
Tanuka Piech, M.D., a cardiologist at the University of Michigan Health Frankel Cardiovascular Center, answers questions about heart disease, why we should care and what we can do to help prevent it.